• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Friday, August 1, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Chemistry

Erythropoietin treatments may increase hip fracture risk in patients with kidney failure

Bioengineer by Bioengineer
May 5, 2021
in Chemistry
Reading Time: 1 min read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

IMAGE

Credit: Dr. Noguchi

Erythropoietin (EPO) is a medication used to stimulate the production of new red blood cells, which is impaired in individuals with kidney failure. Unfortunately, however, the treatment may increase the risk of hip fractures.

In an analysis published in the Journal of Bone and Mineral Research that examined 1997-2013 records from two large U.S. databases, investigators found that EPO doses administered to patients with kidney failure on hemodialysis fluctuated widely over time, and hip fracture rates closely tracked the average dose of EPO doses used in patients.

“Patients with renal failure can benefit from EPO treatment; however, as with all medications, a full understanding of potential drug-associated risks favors the likelihood that a positive risk-benefit balance can be achieved with EPO treatment,” senior author Constance Tom Noguchi, PhD, of the National Institute of Diabetes and Digestive and Kidney Diseases.

###

Media Contact
Wiley Newsroom
[email protected]

Related Journal Article

http://dx.doi.org/10.1002/jbmr.4297

Tags: Critical Care/Emergency MedicineHealth Care Systems/ServicesInternal MedicineMedicine/HealthPainPharmaceutical SciencePublic Health
Share12Tweet8Share2ShareShareShare2

Related Posts

blank

Nanodevice Harnesses Sound Waves to Shape Light, Revolutionizing Displays and Imaging Technologies

August 1, 2025
Here’s a rewritten version of the headline for a science magazine post: ā€œCould Desert Dust Hold the Key to Freezing Clouds?ā€

Here’s a rewritten version of the headline for a science magazine post: ā€œCould Desert Dust Hold the Key to Freezing Clouds?ā€

July 31, 2025

Rice Theoretical Physicist Illuminates Rare High-Field Phase in Superconductivity Research

July 31, 2025

Sunlight Transforms the Chemical Breakdown of Discarded Face Masks

July 31, 2025
Please login to join discussion

POPULAR NEWS

  • Blind to the Burn

    Overlooked Dangers: Debunking Common Myths About Skin Cancer Risk in the U.S.

    60 shares
    Share 24 Tweet 15
  • Dr. Miriam Merad Honored with French Knighthood for Groundbreaking Contributions to Science and Medicine

    46 shares
    Share 18 Tweet 12
  • Study Reveals Beta-HPV Directly Causes Skin Cancer in Immunocompromised Individuals

    37 shares
    Share 15 Tweet 9
  • Engineered Cellular Communication Enhances CAR-T Therapy Effectiveness Against Glioblastoma

    35 shares
    Share 14 Tweet 9

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Blocking Bcl-2 Boosts ER Stress Killing Glioblastoma

T Cell Responses: Controlled vs. Natural Schistosome Infection

Revolutionary Breakthrough: Achieving Exceptional Performance at Significantly Reduced Temperatures!

  • Contact Us

Bioengineer.org Ā© Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org Ā© Copyright 2023 All Rights Reserved.